Mode
Text Size
Log in / Sign up
N/A N=31

A Speech Recognition Application as a Communication Aid for Acute and Critical Care Patients With Tracheostomies

Tracheostomy · Communication · Acute/Critical Illness

Enrolled (actual)
31
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcome: Primary: Number of Participants Using SRAVI at Least Once — 31 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
SRAVI (Speech Recognition Application for the Voice Impaired) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Queen's University, Belfast
Primary completion
Apr 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Using SRAVI at Least Once
31
PRIMARY
Number of Words/Phrases Correctly Identified by SRAVI App
135
SECONDARY
Length of Critical Care Stay
43.5
SECONDARY
Duration of Hospital Length of Stay
66
SECONDARY
Count of Participants With Delirium During Critical Care Stay
21
SECONDARY
Health Related Quality of Life
65
SECONDARY
Number of Patients Experiencing Symptoms of Anxiety and Depression
7
SECONDARY
Post-traumatic Stress Disorder
25
SECONDARY
Cognitive Status
18

Summary

Patients in acute and critical care often undergo a tracheostomy. A tracheostomy is an incision at the front of the neck to insert a breathing tube directly into the airway. The tube sits in place in the airway using an inflated air-filled cuff. This means that no airflow is directed up and out past the vocal cords through the voice box, and speech is not possible. Being unable to speak can cause distress to patients and may place them at an increased risk of harm if they are unable to express their wishes or needs. It can also increase stress for relatives and healthcare staff as they try to understand what patients are trying to say. Usually when patients cannot talk, staff use different items to help, like a pen and paper. A new communication device that runs on a smartphone or tablet has recently been developed. It is for patients with tracheostomies and works by reading lip movements and translating them into words on the device screen. The aim of this study is to find out if providing adult acute and critical care patients who have a tracheostomy with the use of this lip-reading device could improve how they communicate. This study will include: 1. Using the lip-reading device in acute and critical care to test if it helps patients with tracheostomies to communicate better. 2. Interviews with patients, relatives and focus groups/interviews with staff to find out their views on communication including the use of the new lipreading device. 3. Follow-up with patients approximately 3-months after acute/critical care discharge to complete some further questions about their physical and mental health. The study will take place in three critical care units and one acute care unit in Northern Ireland and is expected to last 18 months. The study has been funded by the Public Health Agency Research and Development Division.

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 years and over
  • Patients who acquire a tracheostomy in acute/critical care
  • Patients can move lips in a way that articulates words
  • Able to communicate in English (a current requirement of the technology)

Exclusion Criteria

-Patient declined consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06027866). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search